Literature DB >> 30340002

Primary structure and anticoagulant activity of fucoidan from the sea cucumber Holothuria polii.

Mohamed Ben Mansour1, Rafik Balti2, Lamia Yacoubi3, Véronique Ollivier4, Frédéric Chaubet5, Raoui Mounir Maaroufi1.   

Abstract

Sea cucumber fucoidan is recently endowed with a variety of biological activities. In the present study, we studied the structure and anticoagulant effect of fucoidan from the sea cucumber Holothuria polii (Fuc-Hp). The Fuc-Hp was purified by anion exchange chromatography and its structure was characterized by FT-IR and NMR spectroscopy. Molecular weight measurements were performed by HPSEC-MALLS-dRI. Fuc-Hp anticoagulant activity was measured by activated partial thromboplastin and thrombin times, and by in vitro thrombin inhibition in the presence of antithrombin and heparin cofactor II. The assessment of thrombin generation was investigated using calibrated automated thrombography. Fuc-Hp with a high sulfate content (34.6%) and an average molecular mass of 1376.3 kDa was isolated from H. polii in amount of ~2.7 mg/g dry body wall. Primary structural analysis indicated that Fuc-Hp was mainly composed of a tetrafucose repeating unit branched by glucuronic acid. Fuc-Hp exhibited a high anticoagulant effect mediated essentially by heparin cofactor II and to lesser extent by antithrombin with IC50 values of 0.16 μg/mL and 0.5 μg/mL, respectively. Overall results showed a high anticoagulant activity of Fuc-Hp, which was attributed to the high sulfate content and abundance of disulfated fucose residues of H. polii fucoidan.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anticoagulant activity; Fucoidan; Holothuria polii; Sea cucumber; Thrombin generation

Mesh:

Substances:

Year:  2018        PMID: 30340002     DOI: 10.1016/j.ijbiomac.2018.10.129

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  8 in total

Review 1.  Anti-lung Cancer Marine Compounds: A Review.

Authors:  Mohammad Reza Miri; Afshin Zare; Jamileh Saberzadeh; Neda Baghban; Iraj Nabipour; Amin Tamadon
Journal:  Ther Innov Regul Sci       Date:  2022-01-13       Impact factor: 1.778

2.  Evaluation of MxOy/fucoidan hybrid system and their application in lipase immobilization process.

Authors:  Agnieszka Kołodziejczak-Radzimska; Michał Bielejewski; Andrzej Biadasz; Teofil Jesionowski
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

3.  Anticancer Activity of Fucoidan via Apoptosis and Cell Cycle Arrest on Cholangiocarcinoma Cell.

Authors:  Pathanin Chantree; Kesara Na-Bangchang; Pongsakorn Martviset
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

4.  Extraction, Characterization, and Anticoagulant Activity of a Sulfated Polysaccharide from Bursatella leachii Viscera.

Authors:  Manel Dhahri; Salim Sioud; Rihab Dridi; Mohsen Hassine; Naceur A Boughattas; Fatimah Almulhim; Zeyad Al Talla; Mariusz Jaremko; Abdul-Hamid M Emwas
Journal:  ACS Omega       Date:  2020-06-10

Review 5.  Therapeutic Effects of Fucoidan: A Review on Recent Studies.

Authors:  Sibusiso Luthuli; Siya Wu; Yang Cheng; Xiaoli Zheng; Mingjiang Wu; Haibin Tong
Journal:  Mar Drugs       Date:  2019-08-21       Impact factor: 5.118

Review 6.  Application of fucoidan as treatment for cardiovascular and cerebrovascular diseases.

Authors:  Ke Wang; Xueli Xu; Qiang Wei; Qiong Yang; Jiarui Zhao; Yuan Wang; Xia Li; Kai Ji; Shuliang Song
Journal:  Ther Adv Chronic Dis       Date:  2022-04-12       Impact factor: 5.091

7.  Sea cucumber Cucumaria frondosa fucoidan inhibits osteosarcoma adhesion and migration by regulating cytoskeleton remodeling.

Authors:  Minglei Zhang; Li Chen; Yang Liu; Minghui Chen; Shuang Zhang; Daliang Kong
Journal:  Oncol Rep       Date:  2020-05-19       Impact factor: 3.906

Review 8.  Extracts and Marine Algae Polysaccharides in Therapy and Prevention of Inflammatory Diseases of the Intestine.

Authors:  Natalya N Besednova; Tatyana S Zaporozhets; Tatyana A Kuznetsova; Ilona D Makarenkova; Sergey P Kryzhanovsky; Lydmila N Fedyanina; Svetlana P Ermakova
Journal:  Mar Drugs       Date:  2020-05-31       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.